Evaluation of designed ligands by a multiple screening method: Applicationto glycogen phosphorylase inhibitors constructed with a variety of approaches
Ss. So et M. Karplus, Evaluation of designed ligands by a multiple screening method: Applicationto glycogen phosphorylase inhibitors constructed with a variety of approaches, J COMPUT A, 15(7), 2001, pp. 613-647
Glycogen phosphorylase (GP) is an important enzyme that regulates blood glu
cose level and a key therapeutic target for the treatment of type II diabet
es. In this study, a number of potential GP inhibitors are designed with a
variety of computational approaches. They include the applications of MCSS,
LUDI and CoMFA to identify additional fragments that can be attached to ex
isting lead molecules; the use of 2D and 3D similarity-based QSAR models (H
QSAR and SMGNN) and of the LUDI program to identify novel molecules that ma
y bind to the glucose binding site. The designed ligands are evaluated by a
multiple screening method, which is a combination of commercial and in-hou
se ligand-receptor binding affinity prediction programs used in a previous
study (So and Karplus, J. Comp.-Aid. Mol. Des., 13 (1999), 243-258). Each m
ethod is used at an appropriate point in the screening, as determined by bo
th the accuracy of the calculations and the computational cost. A compariso
n of the strengths and weaknesses of the ligand design approaches is made.